1700629400
1700629401
[24] Nakase Y, Sakakura C, Miyagawa K, et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer, 2005, 92(3)
:562-569.
1700629402
1700629403
[25] Ren J, Dong L, Xu CB, et al. The role of KDR in the interactions between human gastric carcinoma cell and vascular endothelial cell. World J Gastroenterol, 2002, 8
:595-601.
1700629404
1700629405
[26] Ougolkov A, Yamashita K, Bilim V, et al. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Int J Colorectal Dis, 2003, 18
:160-166.
1700629406
1700629407
[27] So JB, Samarasinge K, Raju GC, Moochhala SM, et al. Expression of cell cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients. J Surg Res, 2000, 94
:56-60.
1700629408
1700629409
[28] Nitti D, Belluco C, Mammano E, et al. Low level of p27（Kip1）protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol, 2002, 81
:167-175.
1700629410
1700629411
[29] Wiksten JP, Lundin J, Nordling S, et al. The prognostic value of p27 in gastric cancer. Oncology, 2002, 63
:180-184.
1700629412
1700629413
[30] Yamagata R, Shimoyama T, Fukuda S, et al. cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur J Gastroenterol Hepatol, 2002, 14
:359-363.
1700629414
1700629415
[31] Xue YW, Zhang QF, Zhu ZB, et al. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J Gastroenterol, 2003, 9
:250-253.
1700629416
1700629417
[32] Gao HJ, Yu LZ, Bai JF, et al. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: Hp infection, histological types and staging. World J Gastroenterol, 2000, 6
:848-854.
1700629418
1700629419
[33] Ohno R, Yoshinaga k, Fujita T, et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer, 2001, 91
:1876-1881.
1700629420
1700629421
[34] Leung Wk, To KF, Ng YP, et al. Association between cyclooxygenase-2 over expression and missense p53 mutations in gastric cancer. Br J Cancer, 2001, 84
:335-339.
1700629422
1700629423
[35] Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol, 2002, 80
:79-88.
1700629424
1700629425
[36] Uefuji K, Ichikura T, Shinomiya N, et al. Induction of apoptosis by JTE 522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Anticancer Res, 2000, 20
:4279-4284.
1700629426
1700629427
[37] Kim TI, Lee YC, Lee KH, et al. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun, 2001, 69
:5056-5063.
1700629428
1700629429
[38] Rajnkova A, Moochhala S, Goh PM, et al. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett, 2001, 172
:177-185.
1700629430
1700629431
[39] Kikuchi T, Itoh F, Toyota M, et al. Aberrant methylation and histone deacetylation of cyclooxygenase-2 in gastric cancer. Int J Cancer, 2002, 97
:272-277.
1700629432
1700629433
[40] Akhtar M, Cheng Y, Magno RM, et al. Promoter methylation regulates Helicobacter pylori stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res, 2001, 61
:2399-2403.
1700629434
1700629435
[41] Fan XM, Wong BC, Lin MC, et al. Interleukin 1 beta induces cyclooxygenase-2 expression in gastric cancer cells by the p38 and p44/42 mitogen activated protein kinase signaling pathways. J Gastroenterol Hepatol, 2001, 16
:1098-1104.
1700629436
1700629437
[42] Rugge M, Bersani G, Bertorelle R, et al. Microsatellite instability and gastric non-invasive neoplasia in a high risk population. J Clin Pathol, 2005, 58(8)
:805-810.
1700629438
1700629439
[43] Wang W, Luo HS, Yu BP. Expression of NF-kappaB and human telomerase reverse transcriptase in gastric cancer and precancerous lesions. World J Gastroenterol, 2004, 10(2)
:177-181.
1700629440
1700629441
[44] Kondo T, Oue N, Mitani Y, et al. Loss of heterzygosity and histone hypoacetylation of the PINX 1 gene are associated with reduced expression in gastric carcinoma. Oncogene, 2005, 24(1)
:157-164.
1700629442
1700629443
[45] Deng H, Wu RL, Zhou HY, et al. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer. World J Gastroenterol, 2006, 12(7)
:1013-1017.
1700629444
1700629445
[46] Cheng A S, Chan H L, ToK F. Cyelooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor an giogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int J Oncol, 2004, 24(4)
:853-860.
1700629446
1700629447
[47] Smakman N, Kranenburg O, Vogten JM, et al. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. Clin Cancer Res, 2005, 11(1)
:41-48.
1700629448
1700629449
[48] Ko S, Chu KM, Luk JM, Wong BW, et al. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia andadenocarcinoma of the stomach. J Pathol, 2005, 205
:615-622.
[
上一页 ]
[ :1.7006294e+09 ]
[
下一页 ]